Johnson & Johnson

NYSE: JNJ
$142.06
-$0.21 (-0.1%)
Closing Price on January 10, 2025

JNJ Articles

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. thinkstockMarch 6, 2015: Markets opened lower on Friday...
News finally broke late Wednesday that there was an official buyout of Pharmacyclics in the works by AbbVie for $21 billion.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. courtesy of WhiteHouse.govBerkshire Hathaway Inc. (NYSE:...
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. thinkstockFebruary 17, 2015: Markets opened lower on...
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. thinkstock February 9, 2015: Markets opened lower on...
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. thinkstockFebruary 6, 2015: Markets opened mixed on...
Boston Scientific is pushing forward in its long turnaround and is gathering more speed.
Johnson & Johnson reported better than expected fourth-quarter results Tuesday before the market open.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. thinkstockJanuary 15, 2015: Markets opened higher on...
Thursday's top analyst upgrades, downgrades include Apple, Barrick Gold, Corning, Groupon, Peabody Energy and SolarCity.
Cowen has a long list of stocks that are out of favor at many other firms on Wall Street. These five are leaders in their respective sectors and have big dividends.
One key consideration for the year ahead is that Johnson & Johnson raised its dividends again and managed to have upside performance above what was expected.
For the third consecutive year, the company spending the most on research and development (R&D) was Germany's Volkswagen.
courtesy of WhiteHouse.govBerkshire Hathaway Inc. (NYSE: BRK-A) has released its public equity holdings as of September 30, 2014. Warren Buffett’s portfolio has recently undergone some radical...
Geron hasannounced that it entered into an exclusive worldwide license and collaboration agreement with Janssen Biotech to develop and commercialize imetelstat.
AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.